Stock Ticker

  • Loading stock data...

Celsion Corporation (NASDAQ:CLSN) Announces Translational Data From OVATION Study In Latest Diagnosed Advanced Ovarian Cancer Patients

Celsion Corporation (NASDAQ:CLSN) has recently announced the latest translational data from the OVATION study of the Phase 1b dose clinical trials that combined GEN-1, Company’s 1L-12 gene-mediated immunotherapy, together with standard care for treatment of the lately-diagnosed patients of Stage 3 and 4 ovarian cancer. The patients went through the neoadjuvant chemotherapy (NACT) and afterwards […]

Celsion Corporation (NASDAQ:CLSN) focus on the development, production and commercialization of treatment therapies

Boston, MA 02/07/2013 (wallstreetpr) – Shares of Celsion Corporation (NASDAQ:CLSN) increased by 8.82 percent to close at $1.11 on Monday. The shares recorded an intraday high of $1.14 per share and an intraday low of $1.03 per share during the day. During the last trading session, shares of Celsion Corporation (NASDAQ:CLSN) ranged between a 52-week […]

Celsion Corporation (NASDAQ:CLSN) shares declining in prices with heavy trading volumes

Boston, MA 06/13/2013 (wallstreetpr) – The share prices of Celsion Corporation (NASDAQ:CLSN) had declined by 11.32 percent to close at $1.41 per share for the end of last trading session on Wednesday. The shares of the company had been trading in the range of $1.25 to $1.43 per share during the day. The shares of Celsion […]

Celsion Corporation (NASDAQ:CLSN) shares up by 39.47%

Boston, MA 05/30/2013 (wallstreetpr) – The share prices of Celsion Corporation (NASDAQ:CLSN) had increased by 39.47 percent to close at $1.59 per share for the end of last trading session. The shares of the company had been trading in the range of $1.15 to $1.59 per share during the day. The shares of Celsion Corporation (NASDAQ:CLSN) […]

Sign Up To Get Our Latest Stocks Alerts